AMC Entertainment Holdings announced on June 11, 2026, that it completed a $150 million at-the-market equity offering, issuing about 105.3 million shares. The capital raise aims to improve the company’s financial flexibility and cash reserves as the theater chain operates in a recovering market.
The equity offering follows a strong U.S. box office showing in 2026, with domestic ticket sales up 13 percent compared to the same period in 2025. This performance helped push AMC’s stock up more than 50 percent since the equity offering began in February, according to CEO Adam Aron.
Adam Aron said the equity offering improves AMC’s financial position by raising cash reserves and strengthening the balance sheet. He noted the company remains focused on improving the guest experience, boosting earnings before interest, taxes, depreciation, and amortization (EBITDA), and lowering financial leverage.
Issuing about 105.3 million new shares increased the company’s share count, raising concerns about dilution among investors focused on earnings per share. Simply Wall St reported that the extra shares add risk of shareholder dilution, which matters given AMC’s volatile stock history and high leverage.
Box office performance has influenced investor views. In the 11 weeks through June, six films opened domestically with weekends over $75 million, helping to increase theater attendance. This mix of blockbuster and niche films supported ticket sales that have matched or exceeded industry forecasts.
In May 2026, AMC drew 25.5 million moviegoers, the highest since May 2019 before the pandemic affected attendance. The strong film lineup included A24’s “Backrooms,” Focus Features’ “Obsession,” and Universal’s “Super Mario Galaxy Movie,” all boosting the domestic box office. Some releases held well over time; for example, “Obsession” had an unusually small drop in its fourth weekend.
AMC postponed plans to show live concerts by artists like Bebe Rexha, Paris Hilton, and Maren Morris at some locations. This reflects confidence in studio film releases to keep audiences engaged longer in theaters.
The delay of live concert screenings is a temporary change from AMC’s earlier strategy to diversify entertainment beyond films. The company had aimed to reduce dependence on studio releases by tapping into fanbases of popular musicians. AMC’s prior success with concert screenings, such as Taylor Swift’s “Eras Tour” film, which grossed $261 million worldwide in 2023, shows the value of alternative content.
Analyst Drew Crum of B. Riley raised AMC’s price target to $2.25 from $2 and kept a Buy rating. He noted the unexpectedly strong domestic box office in May and expected more gains in the second quarter. Crum pointed to better release windows and potential benefits from guild renewals. He also warned some of this optimism may already be reflected in the stock price.
AMC projects long-term revenue growth and earnings improvements, targeting $6.1 billion in revenue and $666.7 million in earnings by 2029. Meeting these goals would require annual revenue growth of about 6.5 percent and a large turnaround from recent earnings losses reported at minus $547.4 million.
The capital raised will help AMC manage liquidity and debt levels short term. With the U.S. box office recovering, AMC’s adjustments aim to create value for shareholders while addressing financial leverage. The company focuses on sustaining the theater experience and improving profitability amid competition from streaming and changing customer habits.
This equity offering gives AMC financial flexibility to pursue long-term goals with a stronger balance sheet. The market remains watchful of dilution effects and AMC’s ability to turn box office gains into real profits and cash flow in coming years.
